For patients who require long-term use of Upadacitinib to control conditions such as rheumatoid arthritis and atopic dermatitis, the generic version l···【Read More】
Update: 2026-06-03Source: Haiou HealthViews: 75
In the field of autoimmune disease drugs, the Dabear version of Upadacitinib from Laos is gradually becoming a new hope for patients in low- and middl···【Read More】
Update: 2026-06-03Source: Haiou HealthViews: 76
Upadacitinib produced by Lao Big Bear Pharmaceutical Company, as a legal generic version of the originator upadacitinib, provides a more cost-controll···【Read More】
Update: 2026-06-03Source: Haiou HealthViews: 76
Against the backdrop of increasing challenges in access to innovative drugs, the Laos Dabear version of Sotorasib, with its active ingredients highly ···【Read More】
Update: 2026-06-03Source: Haiou HealthViews: 76
In recent years, the quietly emerged Lao Big Bear version of Sotorasib, an affordable alternative to this targeted therapy for refractory KRAS G12C mu···【Read More】
Update: 2026-06-03Source: Haiou HealthViews: 75
The Laotian Bear version of Sotorasib, as the first generic version of the world's first approved KRAS G12C inhibitor original drug, is produced b···【Read More】
Update: 2026-06-03Source: Haiou HealthViews: 76
In today's context of increasing attention to targeted anti-tumor drugs, the Laos Dabear version of Encorafenib, with its compliant production bac···【Read More】
Update: 2026-06-02Source: Haiou HealthViews: 84
As one of the first generic versions of the original drug Encorafenib, the Lao Big Bear version of Encorafenib, with proven equivalence and significan···【Read More】
Update: 2026-06-02Source: Haiou HealthViews: 81
The generic version of Encorafenib launched by Lao Big Bear Pharmaceutical provides a more accessible option for patients worldwide who need BRAF inhi···【Read More】
Update: 2026-06-02Source: Haiou HealthViews: 83
The Laos Daxiong version of Axitinib strictly adheres to international generic drug production standards, providing clinicians and patients with a val···【Read More】
Update: 2026-06-02Source: Haiou HealthViews: 80
Against the backdrop of increasing global demand for anticancer drugs, the Laos Dabear version of Axitinib, with its relatively accessible cost and st···【Read More】
Update: 2026-06-02Source: Haiou HealthViews: 82
As a key targeted drug for advanced renal cell carcinoma, the Laos Big Bear version of Axitinib provides a new treatment option for patients with meta···【Read More】
Update: 2026-06-02Source: Haiou HealthViews: 81
The Laos Dabear version of Avatrombopag, as a generic drug option in emerging markets, provides a more accessible treatment choice for patients who ne···【Read More】
Update: 2026-06-01Source: Haiou HealthViews: 84
Selpercatinib is a highly selective RET kinase inhibitor used to treat various solid tumors, including non-small cell lung cancer and medullary thyroi···【Read More】
Update: 2026-05-29Source: Haiou HealthViews: 99
Selpercatinib is a highly selective RET kinase inhibitor used for the treatment of various cancers (such as non-small cell lung cancer, medullary thyr···【Read More】
Update: 2026-05-29Source: Haiou HealthViews: 90
Copyright2024@ BIGBEAR All right reserved Bigbear | Bigbear Pharmaceutical | Bigbear Laos



